Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells

Fig. 3

LGMSCs and LGMSC-Exos treatment reduced inflammatory infiltration and improved saliva flow rate in NOD mice. A Grouping and treatment of mice. B The saliva flow rate of mice in different groups. C Histology of the salivary glands of mice in different groups. Data are shown as mean ± standard deviation (SD) from three independent experiments. ***p < 0.001, **p < 0.01, *p < 0.05. D Statistical results of the number of inflammatory foci. E Statistical results of the ratio of the area of foci to the total area of glandular tissue. *p < 0.05 compared with NOD + PBS group. HCQ hydroxychloroquine; LGMSCs labial gland-derived mesenchymal stem cells; LGMSC-Exos LGMSC-derived exosomes

Back to article page